Cognitive functions and PANSS scores in a cohort of patients with schizophrenia treated with olanzapine

被引：0
|
作者：
Borkowska, A. [1 ]
Bielinski, M. [1 ]
Drozdz, W. [1 ]
机构：
[1] Nicholas Copernicus Univ, Torun Coll Med, Clin Neuropsychol Unit, Bydgoszcz, Poland
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2009年 / 19卷
关键词：
IMPAIRMENT;
D O I：
10.1016/S0924-977X(09)70844-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S531 / S532
页数：2
相关论文
共 50 条
  • [31] Aripiprazole Added to Overweight and Obese Olanzapine-Treated Schizophrenia Patients
    Henderson, David C.
    Fan, Xiaoduo
    Copeland, Paul M.
    Sharma, Bikash
    Borba, Christina P.
    Boxill, Ryan
    Freudenreich, Oliver
    Cather, Corinne
    Evins, A. Eden
    Goff, Donald C.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 29 (02) : 165 - 169
  • [32] Neurocognitive performance and clinical changes in olanzapine-treated patients with schizophrenia
    Gur, RE
    Kohler, C
    Ragland, JD
    Siegel, SJ
    Bilker, WB
    Loughead, J
    Phend, N
    Gur, RC
    NEUROPSYCHOPHARMACOLOGY, 2003, 28 (11) : 2029 - 2036
  • [33] Decreased bone mineral density in patients with schizophrenia treated with risperidone or olanzapine
    Wyszogrodzka-Kucharska, A.
    Rabe-Jablonska, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S408 - S409
  • [34] Extrapyramidal symptom profiles in Japanese patients with schizophrenia treated with olanzapine or haloperidol
    Inada, T
    Yagi, G
    Miura, S
    SCHIZOPHRENIA RESEARCH, 2002, 57 (2-3) : 227 - 238
  • [35] Prolactin response in patients with schizophrenia treated with haloperidol, clozapine, risperidone and olanzapine
    Potkonjak, Jelena
    Karlovic, Dalibor
    Bukovec, Zeljka
    Baricevic, Tihana
    BIOCHEMIA MEDICA, 2009, 19 (01) : 73 - 80
  • [36] Can the panss cognitive factor be a valid surrogate for neurocognition in schizophrenia?
    Sethuraman, G
    Ahmed, S
    Rock, SL
    Young, CA
    Marquez, EM
    Purdon, SE
    Keefe, RS
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S226 - S226
  • [37] Metabolic syndrome among patients with schizophrenia treated with aripiprazole, placebo or olanzapine
    Allison, D. B.
    L'Italien, G.
    Vester-Blokland, E.
    McQuade, R.
    Carson, W. H.
    Marcus, R. N.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S283 - S283
  • [38] Sexual dysfunction in male schizophrenia remitted patients treated with risperidone and olanzapine
    不详
    INDIAN JOURNAL OF PSYCHIATRY, 2022, 64
  • [39] Neurocognitive Performance and Clinical Changes in Olanzapine-Treated Patients with Schizophrenia
    Raquel E Gur
    Christian Kohler
    J Daniel Ragland
    Steven J Siegel
    Warren B Bilker
    James Loughead
    Nick Phend
    Ruben C Gur
    Neuropsychopharmacology, 2003, 28 : 2029 - 2036
  • [40] Taurine and glutathione in plasma and cerebrospinal fluid in olanzapine treated patients with schizophrenia
    Samuelsson, Martin
    Skogh, Elisabeth
    Lundberg, Kristina
    Vrethem, Magnus
    Ollinger, Karin
    PSYCHIATRY RESEARCH, 2013, 210 (03) : 819 - 824
12345